691,167 Shares in Baxter International Inc. $BAX Purchased by Hsbc Holdings PLC

Hsbc Holdings PLC bought a new position in shares of Baxter International Inc. (NYSE:BAX) during the second quarter, Holdings Channel reports. The fund bought 691,167 shares of the medical instruments supplier’s stock, valued at approximately $14,748,000.

Several other hedge funds have also made changes to their positions in BAX. BlackRock Inc. purchased a new stake in shares of Baxter International during the 2nd quarter valued at approximately $1,744,874,000. Pzena Investment Management LLC purchased a new position in Baxter International in the second quarter worth approximately $1,392,098,000. Geode Capital Management LLC increased its stake in Baxter International by 7.8% during the fourth quarter. Geode Capital Management LLC now owns 13,510,205 shares of the medical instruments supplier’s stock worth $257,174,000 after acquiring an additional 972,891 shares during the last quarter. Ameriprise Financial Inc. raised its position in Baxter International by 1.3% in the second quarter. Ameriprise Financial Inc. now owns 7,638,629 shares of the medical instruments supplier’s stock valued at $231,304,000 after purchasing an additional 97,687 shares during the period. Finally, Equity Investment Corp acquired a new position in shares of Baxter International in the 2nd quarter valued at $146,815,000. Hedge funds and other institutional investors own 90.19% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on BAX shares. TD Cowen raised their price objective on Baxter International from $20.00 to $24.00 and gave the stock a “hold” rating in a research report on Monday, July 27th. Weiss Ratings raised shares of Baxter International from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, July 31st. UBS Group lifted their price target on shares of Baxter International from $19.00 to $25.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Stifel Nicolaus upped their price objective on shares of Baxter International from $19.00 to $24.00 and gave the stock a “hold” rating in a report on Tuesday, July 28th. Finally, The Goldman Sachs Group upped their price target on Baxter International from $19.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. Two equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $22.45.

Baxter International Trading Down 2.0%

NYSE:BAX opened at $25.97 on Friday. The firm has a market cap of $13.43 billion, a PE ratio of -12.55, a price-to-earnings-growth ratio of 4.01 and a beta of 0.60. The stock has a fifty day moving average price of $24.12 and a 200 day moving average price of $20.51. Baxter International Inc. has a 12-month low of $15.73 and a 12-month high of $30.00. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.19. The company had revenue of $2.96 billion for the quarter, compared to the consensus estimate of $2.80 billion. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%.Baxter International’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.59 EPS. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. Sell-side analysts anticipate that Baxter International Inc. will post 2.04 earnings per share for the current fiscal year.

Baxter International Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Friday, August 28th will be paid a $0.01 dividend. The ex-dividend date is Friday, August 28th. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. Baxter International’s payout ratio is currently -1.93%.

Baxter International Company Profile

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.